Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir disoproxil fumarate in chronic hepatitis B patients with suboptimal response to adefovir-based therapy
2007-001789-34Phase 3Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tenofovir disoproxil fumarate and lamivudine in Chronic Hepatitis B (CHB) (2 arms), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoint: Optimal suppression of HBV replication and control of liver disease. Started Jan 2008; status: active.
02
Drugs
tenofovir disoproxil fumaratelamivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2007-001789-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001789-34.